Financial News
Latest News about Health care industry
Recent news which mentions Health care industry
Ozempic is driving up the cost of your health care, whether you can get your hands on it or not
October 11, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
Pfizer threatened to sue renegade executives prior to activist schism, Starboard's Smith says
October 10, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
Ozempic underworld: Inside the black market of obesity drugs
October 09, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
Recursion gets FDA approval to begin phase 1 trials of AI-discovered cancer treatment
October 02, 2024
From CNBC.com News
Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline
October 02, 2024
From CNBC.com News
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
October 01, 2024
From CNBC.com News
CVS is working with advisors on strategic review, sources say
September 30, 2024
From CNBC.com News
Major CVS shareholder plans activist push, will meet with management, sources say
September 29, 2024
From CNBC.com News
Harris leads with Latino voters, but the economy narrows the margin for Dems: Survey
September 29, 2024
From CNBC.com News
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
September 26, 2024
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
September 25, 2024
From CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
September 24, 2024
From CNBC.com News
From CNBC.com News
FTC sues drug middlemen for allegedly inflating insulin prices
September 20, 2024
From CNBC.com News
Pesky medical bill? Most people don't take a key step to manage that debt, study finds
September 20, 2024
From CNBC.com News
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
September 18, 2024
From CNBC.com News
23andMe CEO Anne Wojcicki 'surprised and disappointed' by board resignations: Read the memo
September 17, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.